サンバイオ株式会社 · Pharmaceutical · FY ends Jan
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|---|---|---|---|---|
| 1 | 川西 徹 | 12,221,186 | 15.66% | — | — |
| 2 | 森 敬太 | 5,997,284 | 7.68% | — | — |
| 3 | 株式会社SBI証券 | 1,294,829 | 1.65% | — | — |
| 4 | 野村證券株式会社
Asset-management company of 野村 浩子 |
1,147,291 | 1.47% | — | — |
| 5 | 大高 功 | 500,000 | 0.64% | — | — |
| 6 | マネックス証券株式会社 | 444,013 | 0.56% | — | — |
| 7 | 松井証券 株式会社 | 264,900 | 0.33% | — | — |
| 8 | SMBC日興証券株式会社 | 244,099 | 0.31% | — | — |
| 9 | 安井 勝孝 | 229,500 | 0.29% | — | — |
| 10 | GMOクリック証券株式会社 | 223,700 | 0.28% | — | — |
| Name | Title | Shares | Value | Pay |
|---|---|---|---|---|
| 川西 徹 | Chairman & Representative Director | 12,221,186 | — | — |
| 森 敬太 | President, Representative Director & Executive Officer | 5,997,284 | — | — |
| Noboru Furuya | Director | 157,143 | — | — |
| 棚橋 正顕 | Full-time Audit & Supervisory Board Member | — | — | — |
| 植田 俊道 | Audit & Supervisory Board Member | 6,329 | — | — |
| 山角 健 | Audit & Supervisory Board Member | 40,000 | — | — |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|---|---|---|---|---|
| FY ending Jan 2026 | — | ¥-52.55 | — | — | 78,033,331 |
| FY ending Jan 2025 | — | ¥-41.86 | — | — | 70,927,202 |
| FY ending Jan 2024 | — | ¥-40.48 | — | — | 67,929,202 |
| FY ending Jan 2023 | — | ¥-95.99 | — | — | 64,076,202 |
| FY ending Jan 2022 | — | ¥-90.33 | — | — | 51,793,402 |
| FY ending Jan 2021 | — | ¥-65.38 | — | — | 51,785,505 |
| FY ending Jan 2020 | — | ¥-100.91 | — | — | 51,785,023 |
| FY ending Jan 2019 | — | ¥-60.17 | — | — | 49,732,868 |
| FY ending Jan 2018 | — | ¥-86.85 | — | — | 45,492,281 |
| FY ending Jan 2017 | — | ¥-40.88 | — | — | 45,109,032 |